451 - 475 of 33.628
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Cintas Corp USD Call 250,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 11,30x
- Analysis
- Orange S.A. Call 20,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 11,56x
- Analysis
- Continental Call 65,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 13,50x
- Analysis
- AMD Call 320,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 2,34x
- Analysis
- Fincantieri Call 22,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 2,54x
- Analysis
- Continental Call 65,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 10,77x
- Analysis
- Sanofi Call 105,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 13,91x
- Analysis
- Cintas Corp USD Call 200,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 4,30x
- Analysis
- Cintas Corp USD Call 200,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 18,16x
- Analysis
- Salzgitter Call 26,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,49x
- Analysis
- Fresenius Call 45,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 3,88x
- Analysis
- Cintas Corp USD Call 200,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 8,75x
- Analysis
- The Swatch Group Call 180,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 5,36x
- Analysis
- Wells Fargo & Co Call 130,00 16 Jan 2026
- Goldman Sachs
- 16.01.26
- 7,90x
- Analysis
- Carl Zeiss Meditec Call 65,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 8,46x
- Analysis
- The Swatch Group Call 260,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 10,54x
- Analysis
- Continental Call 70,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 6,36x
- Analysis
- Cintas Corp USD Call 240,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 10,97x
- Analysis
- Continental Call 70,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 5,47x
- Analysis
- Cintas Corp USD Call 180,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 3,69x
- Analysis
- Cintas Corp USD Call 180,00 18 Jun 2026
- Goldman Sachs
- 18.06.26
- 4,85x
- Analysis
- Cintas Corp USD Call 240,00 16 Jan 2026
- Goldman Sachs
- 16.01.26
- 12,30x
- Analysis
- Newmont Goldcorp Call 160,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,15x
- Analysis
- Johnson & Johnson Call 260,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 9,63x
- Analysis
- Morgan Stanley Call 240,00 16 Jan 2026
- Goldman Sachs
- 16.01.26
- 9,67x
- Analysis